Related Experiment Video
Updated: May 18, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Exercise physiology and pulmonary arterial hypertension
1Pulmonary Vascular Disease Program, Dyspnea and Exercise Intolerance Center, Pulmonary Critical Care Medicine, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. abwaxman@partners.org
Pulmonary artery hypertension (PAH) involves vascular remodeling, increasing pulmonary vascular resistance and pressure. This burdens the right ventricle, potentially causing heart failure, highlighting the need to study pressure-flow dynamics.
Area of Science:
- Cardiovascular Physiology
- Pulmonary Medicine
- Pathophysiology
Background:
- The pulmonary circulation is a high-flow, low-resistance system.
- Pulmonary artery hypertension (PAH) involves elevated pulmonary vascular resistance (PVR) and pulmonary artery pressure (PAP).
- Vascular remodeling, including smooth muscle cell proliferation and endothelial cell proliferation, causes lumen obliteration in PAH.
Purpose of the Study:
- To investigate the pressure-flow relationships within the pulmonary vascular bed.
- To enhance understanding of the pathophysiology of pulmonary hypertension.
- To elucidate the mechanisms leading to right-sided heart failure in PAH.
Main Methods:
- Analysis of pressure-flow dynamics in the pulmonary circulation.
- Assessment of vascular remodeling markers.
- Evaluation of right ventricular function and workload.
Main Results:
- Vascular remodeling in PAH leads to sustained increases in PVR and PAP.
- Elevated PVR and PAP create an excessive workload for the right ventricle.
- Loss of pulmonary arterial compliance contributes to the increased vascular resistance.
Conclusions:
- Understanding pressure-flow relationships is crucial for appreciating PAH pathophysiology.
- The functional status of the pulmonary circulation dictates patient outcomes in PAH.
- Study findings underscore the link between vascular remodeling, hemodynamic changes, and right-sided heart failure in PAH.
More Related Videos
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Pulmonary Edema II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...